And another autologous cellular therapy approved by the FDA. The door is wide open for OCC to walk through with a well trialled autlogous stem cell therapy, without the potency assay contentions of theapies like MSB's. The FDA has been showing itself very open to autologous cellular therapies. This is a defined change to pre-COVID.
https://www.onclive.com/view/fda-grants-orphan-drug-designation-to-mb-106-for-waldenstr-m-macroglobulinemia
I know investors are sick to death of hearing me and a "very excited" CEO, but the regulatory environment for ATI is much improved. Fingers, toes and any other extemities crossed that J&J sees this and joins OCC in a phase III partnership with OCC in the US, for a very now much more established and trodden path to approval in an autlogous cellular therapy.
- Forums
- ASX - By Stock
- Stem Cell Therapy advancements
And another autologous cellular therapy approved by the FDA. The...
-
- There are more pages in this discussion • 175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
-0.015(3.23%) |
Mkt cap ! $94.30M |
Open | High | Low | Value | Volume |
47.0¢ | 47.0¢ | 44.8¢ | $101.0K | 221.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 6739 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 9799 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 6739 | 0.445 |
3 | 82109 | 0.440 |
2 | 19005 | 0.430 |
1 | 40000 | 0.425 |
3 | 18904 | 0.420 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 9799 | 1 |
0.455 | 30999 | 1 |
0.460 | 2173 | 1 |
0.465 | 7230 | 2 |
0.470 | 68073 | 4 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online